Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lan, Jianping
NCT04803929: Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)	Recruiting	1	25	RoW	anti-ILT3 CAR-T	Carbiogene Therapeutics Co. Ltd., Zhejiang Provincial People's Hospital	AML M4, AML M5	03/24	03/26
NCT05376345: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma	Recruiting	1	32	RoW	LCAR-BCDR cells product	Weijun Fu, Nanjing Legend Biotech Co.	Relapsed/Refractory Multiple Myeloma	06/24	09/26
Jin, Lai
NCT04803929: Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)	Recruiting	1	25	RoW	anti-ILT3 CAR-T	Carbiogene Therapeutics Co. Ltd., Zhejiang Provincial People's Hospital	AML M4, AML M5	03/24	03/26